Paramount Bed Holdings Co., Ltd.

7817.T
Medical Instruments & Supplies
2026/02/09 Updated
Market Cap: $1.3B (¥197.1B)
Stock Price: $22.88 (¥3,515)
Exchange Rate: 1 USD = ¥153.61

Notice Regarding Resolution for Approval of Stock Consolidation, Abolition of the Designation of Number of Shares per Unit, and Partial Amendment of Articles of Incorporation

The total number of issued shares will decrease by 56,075,836 shares due to the stock consolidation, and after the effective date of February 9, 2026, the total issued shares will be 3 shares. Delisting is scheduled for February 5, 2026.

Importance:
Page Updated: January 19, 2026
IR Disclosure Date: January 19, 2026

Key Figures

  • Stock Consolidation Ratio: Consolidation of 16,034,050 shares into 1 share
  • Decrease in Total Issued Shares: 56,075,836 shares
  • Total Issued Shares After Effectiveness: 3 shares

AI要約

Overview of Capital Policy

Paramount Bed Holdings Co., Ltd. announced the proposal regarding stock consolidation, abolition of the designation of number of shares per unit, and partial amendment of the Articles of Incorporation in a press release dated December 12, 2025, which was approved as originally proposed at the extraordinary general meeting of shareholders on January 19, 2026. The stock consolidation involves consolidating 16,034,050 shares into 1 share, resulting in a decrease of 56,075,836 shares in the total issued shares, leaving 3 shares outstanding. Along with this, the designation of the number of shares per unit will be abolished, and partial amendments to the Articles of Incorporation will be made.

Impact on Shareholders and Future Schedule

As a result of the stock consolidation, the company’s shares will meet the criteria for delisting from the Tokyo Stock Exchange, and will be designated as a securities to be delisted from January 19 to February 4, 2026, with delisting scheduled on February 5. Fractional shares will be purchased by TMKR Co., Ltd., the tender offeror, with court approval, and the proceeds will be distributed to shareholders around mid-May 2026. The authorized number of shares will be changed to 12 shares, and the shareholders will be limited to the tender offeror and Tomohiko Kimura, Representative Director and President.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.